Showing results (1971-1980 of 2,247) with videos related to

Sort By:
Pageof 225
Cell Death & Disease|August 16, 2022
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilitiesOzlem Yedier-Bayram, Bengul Gokbayrak, Alisan Kayabolen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2022
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective TrialKala Visvanathan, Leslie Cope, Mary Jo Fackler, et al.
Journal of the American Heart Association|May 3, 2022
Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO StudyTomas Kovarnik, Matsuo Hitoshi, Ales Kral, et al.
Cancers|January 28, 2026
Analytical Validation and Clinical Sensitivity of the Belay Summit™ 2.0 Cerebrospinal Fluid Liquid Biopsy Test-An Expanded Comprehensive Genomic Profiling Platform for Central Nervous System MalignanciesSakshi Khurana, Viriya Keo, Alexandra Larson, et al.
Journal of the National Cancer Institute|July 7, 2025
Discovering plasma proteins associated with breast cancer incidence in post-menopausal women in ARICMaria-Eleni Syleouni, Corinne E Joshu, Josef Coresh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker StudyKala Visvanathan, MaryJo S Fackler, Zhe Zhang, et al.
Breast Cancer Research and Treatment|March 24, 2010
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysisPatricia G Moorman, Edwin S Iversen, P Kelly Marcom, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 19, 2021
Prediagnostic Antibody Responses to Fusobacterium nucleatum Proteins Are Not Associated with Risk of Colorectal Cancer in a Large U.S. ConsortiumChun-Han Lo, William J Blot, Lauren R Teras, et al.
Microorganisms|November 4, 2020
Association of Combined Sero-Positivity to Helicobacter pylori and Streptococcus gallolyticus with Risk of Colorectal CancerMeira Epplein, Loïc Le Marchand, Timothy L Cover, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 10, 2026
β-Adrenergic Signaling Promotes Anti-Tumor Immunity in TP53-mutant Oral Squamous Cell CarcinomaFrederico O Gleber-Netto, Deborah Silverman, Tongxin Xie, et al.
Pageof 225